168 related articles for article (PubMed ID: 2146081)
1. Will 99mTc-MAG3 replace 131I-OIH and 99mTc-DTPA in the follow-up of renal transplants?
Dubovsky EV; Russell CD; Yester MV; Thorstad BL; Ryan JP
Contrib Nephrol; 1990; 79():118-22. PubMed ID: 2146081
[No Abstract] [Full Text] [Related]
2. [Functional parameters calculated by 99mTc-MAG3 in transplanted kidney].
Koizumi K; Yamaguchi M; Tooyama K; Uchiyama G; Yamada Y; Ueno A
Kaku Igaku; 1994 Jan; 31(1):17-25. PubMed ID: 8309107
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of 99mTc-MAG3 renal imaging: comparison with 99mTc-DTPA, 99mTc-DMSA and 131I-OIH].
Adachi I; Sueyoshi K; Sugioka Y; Komori T; Ogura Y; Tabuchi K; Nakata Y; Namba R; Tatsu Y; Matsui R
Kaku Igaku; 1994 Feb; 31(2):131-42. PubMed ID: 8121069
[TBL] [Abstract][Full Text] [Related]
4. [A comparative evaluation of iodine-131 OIH and technetium-99m MAG3 in the study of renal function].
Di Lorenzo I; Stiglich F; Barbonetti C; Bonomo F; Maspero S; Paini S; Bottinelli G
Radiol Med; 1990 Apr; 79(4):376-80. PubMed ID: 2143030
[TBL] [Abstract][Full Text] [Related]
5. Transplant renography: 99m-Tc-DTPA versus 99m-Tc-MAG3. A preliminary note.
Fraile M; Castell J; Buxeda M; Cuartero A; Cantarell C; Domenech-Torné FM
Eur J Nucl Med; 1989; 15(12):776-9. PubMed ID: 2533892
[TBL] [Abstract][Full Text] [Related]
6. [Advantages of the new radiopharmaceutic agent, 99mTC-mercaptoacetyltriglycine (99mTc-MAG3), in the diagnosis of kidneydiseases. A comparative study with 131I-OIH, 99mTc-DTPA and 99mTc-DMSA].
Lepej J; Marosová A; Kliment J; Buchanec J; Svitác J; Klisenbauer L
Bratisl Lek Listy; 1992 May; 93(5):258-65. PubMed ID: 1327424
[TBL] [Abstract][Full Text] [Related]
7. [99mTc-MAG3 and 131I-OIH in patients with kidney insufficiency and with normal kidneys].
Keske U; Cordes M; Wilfling M; Hunger J; Hosten N; Gahl G
Rofo; 1990 Mar; 152(3):287-92. PubMed ID: 2157251
[TBL] [Abstract][Full Text] [Related]
8. Radiation dosimetry for technetium-99m-MAG3, technetium-99m-DTPA, and iodine-131-OIH based on human biodistribution studies.
Stabin M; Taylor A; Eshima D; Wooter W
J Nucl Med; 1992 Jan; 33(1):33-40. PubMed ID: 1530968
[TBL] [Abstract][Full Text] [Related]
9. [Phase 3 clinical study of 99mTc-MAG3 injectable, a dynamic renal imaging agent--comparison with 123I-OIH and 99mTc-DTPA].
Torizuka K; Ishibashi A; Ikekubo K; Yamamoto K; Nishibuchi S
Kaku Igaku; 1994 Feb; 31(2):183-98. PubMed ID: 8121074
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 99Tcm-mercaptoacetyltriglycine and 131I-orthoiodohippurate in determination of effective renal plasma flow (ERPF).
Abdel-Dayem HM; Sadek S; al-Bahar R; Sabha M; el-Sayed M
Nucl Med Commun; 1989 Feb; 10(2):99-107. PubMed ID: 2525236
[TBL] [Abstract][Full Text] [Related]
11. Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders.
Kabasakal L; Turoğlu HT; Onsel C; Ozker K; Uslu I; Atay S; Cansiz T; Sönmezoğlu K; Altiok E; Isitman AT
J Nucl Med; 1995 Feb; 36(2):224-8. PubMed ID: 7830118
[TBL] [Abstract][Full Text] [Related]
12. Quantitation of renal function using MAG3.
Russell CD; Dubovsky EV
J Nucl Med; 1991 Nov; 32(11):2061-3. PubMed ID: 1834813
[No Abstract] [Full Text] [Related]
13. Measurements of 99mTc-MAG3 uptake in renal transplant recipients.
Oei HY; Surachno S; Wilmink JM; van der Schoot JB
Contrib Nephrol; 1990; 79():113-7. PubMed ID: 2146080
[No Abstract] [Full Text] [Related]
14. Technetium-99m-MAG3 versus iodine-123-OIH: renal clearance and distribution volume as measured by a constant infusion technique.
Prenen JA; de Klerk JM; van het Schip AD; van Rijk PP
J Nucl Med; 1991 Nov; 32(11):2057-60. PubMed ID: 1834812
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of renograms with simultaneous injection of 99mTc-DTPA and 131I-OIH--estimation of GFR, ERPF and retention function of individual kidney].
Maeda M; Hasegawa R; Tanaka S; Yoshida H
Kaku Igaku; 1985 Sep; 22(9):1341-52. PubMed ID: 3910897
[No Abstract] [Full Text] [Related]
16. [Evaluation of renal function using 99mTc-MAG3: comparison with 123I-OIH and 99mTc-DTPA].
Takayama T; Aburano T; Shuke N; Yokoyama K; Michigishi T; Sun BF; Tonami N; Hisada K; Takabatake T; Ohta H
Kaku Igaku; 1993 Jul; 30(7):753-60. PubMed ID: 8377298
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of renal function using 99mTc-MAG3 comparison with 131I-OIH by simultaneous dual energy peak acquisition method].
Hashimoto T; Matsumoto K; Ishibashi R; Iwasaki R; Sanmiya T; Hashimoto J; Kunieda E; Nakamura K; Kubo A
Kaku Igaku; 1995 Feb; 32(2):139-46. PubMed ID: 7715099
[TBL] [Abstract][Full Text] [Related]
18. Tc-99m MAG3 as an alternative to Tc-99m DTPA and I-131 Hippuran for renal transplant evaluation.
O'Malley JP; Ziessman HA; Chantarapitak N
Clin Nucl Med; 1993 Jan; 18(1):22-9. PubMed ID: 8422715
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m DTPA dimethyl ester: a renal function imaging agent. Comparative studies in animals with technetium-99m mercaptoacetyl triglycine and 131I-ortho-iodohippurate.
Bhowal K; Bhattacharyya S; Majumdar A; Giri C; Vanaja R; Ramamoorthy N; Ganguly S; Sarkar BR; Banerjee S; Chatterjee Debnath M
Nucl Med Commun; 2003 May; 24(5):583-95. PubMed ID: 12717078
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of renal function study using 99mTc-DTPA--comparative study with 111In-DTPA and 123I-OIH].
Honda M; Tomonobu M; Kanao K; Miyauchi T; Kamibayashi K; Ota N; Matsuyuki Y
Radioisotopes; 1984 Jul; 33(7):463-6. PubMed ID: 6390542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
